The use of long-acting injectable (LAI) antipsychotic medication is considered a recommended treatment for patients who have difficulty taking daily oral medication, although authors of this article found the use of these LAIs to be underutilized for a variety of reasons. These include provider hesitancy in prescribing LAIs for patients and general misunderstandings of the treatment. Investigators examine two cohorts of patients diagnosed with schizophrenia in a community health setting. Recommendations are made to reduce barriers for patients and providers in adopting this treatment. A five-point checklist to aid in identifying patients who may benefit from LAIs is also offered.